NCT04100720View on ClinicalTrials.gov

Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 29, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2030

Conditions
Tricuspid Regurgitation
Interventions
DEVICE

Cardiovalve Transfemoral Tricuspid Valve

The Cardiovalve Transfemoral Tricuspid Valve System is intended for use in patients with severe, symptomatic Tricuspid regurgitation

Trial Locations (3)

10032

Columbia University Medical Center / NYPH, New York

10461

Montefiore Medical Center, The Bronx

60611

Northwestern University / Bluhm Cardiovascular Institute, Chicago

Sponsors

Collaborators (1)

Cardiovalve Ltd.
All Listed Sponsors
collaborator

Cardiovalve Ltd.

INDUSTRY

collaborator

Cardiovascular Research Foundation, New York

OTHER

lead

Boston Biomedical Associates

OTHER

NCT04100720 - Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation | Biotech Hunter | Biotech Hunter